PCT/2001/45 - World Intellectual Property Organization

45/2001
20176 PCT Gazette - Section I - Gazette du PCT 8 Nov/nov 2001
DZ EE ES FI GB GD GE GH GM HR HU
ID IL IN IS JP KE KG KP KR KZ LC LK
LR LS LT LU LV MA MD MG MK MN MW
MX MZ NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ VN
YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 C12N 15/12, 15/11, 15/62, C07K 14/47,
14/71, 14/72, C12Q 1/68, G01N 33/53,
33/68
(11) WO 01/83751 (13) A2
(21) PCT/US01/13631
(22) 27 Apr/avr 2001 (27.04.2001)
(25) en (26) en
(30) 60/200,590 28 Apr/avr 2000 US
(28.04.2000)
(43) 8 Nov/nov 2001 (08.11.2001)
(54) METHODS FOR BINDING AN EXOGE-
NOUS MOLECULE TO CELLULAR
CHROMATIN
METHODES DE FIXATION D’UNE
MOLECULE EXOGENE A LA CHRO-
MATINE CELLULAIRE
(71) SANGAMO BIOSCIENCES, INC.
[US/US]; Point Richmond Tech Center,
Suite A100, 501 Canal Blvd., Richmond, CA
94804 (US).
(72) RASCHKE, Eva; 1626 Berkeley Way #B,
Berkeley, CA 94703 (US). WOLFFE, Alan,
P.; 155 Alice Lane, Orinda, CA 94563 (US).
CASE, Casey, C.; 605 Barriolhet Avenue,
San Mateo, CA 94022 (US).
(74) PASTERNAK, Dahna, S.; Robins & Associates,
90 Middlefield Road, Suite 200, Menlo
Park, CA 94025 (US) et al. / etc.
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC
LK LR LS LT LU LV MA MD MG MK MN
MW MX MZ NO NZ PL PT RO RU SD SE
SG SI SK SL TJ TM TR TT TZ UA UG UZ
VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 C12N 15/12, 15/62, 15/70, 15/85, 5/10,
C07K 14/705, 16/28, C12Q 1/68, G01N
33/50, 33/68
(11) WO 01/83752
(21) PCT/US01/13722
(13) A2
(22) 27 Apr/avr 2001 (27.04.2001)
(25) en (26) en
(30) 60/200,689 29 Apr/avr 2000
(29.04.2000)
US
(43) 8 Nov/nov 2001 (08.11.2001)
(54) 23949 AND 32391, NOVEL HUMAN
ION CHANNELS AND USES THEREOF
23949 ET 32391, NOUVEAUX CANAUX
IONIQUES HUMAINS, ET UTILISA-
TION ASSOCIEE
(71) MILLENNIUM PHARMACEUTICALS,
INC. [US/US]; 75 Sidney Street, Cambridge,
MA 02139 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) GLUCKSMANN, Maria, A. [US/US];
33 Summit Road, Lexington, MA 02173
(US). CURTIS, Rory, A., J. [US/US];
31 Constitution Drive, Southborough, MA
01772 (US).
(74) MANDRAGOURAS, Amy, E. et al. / etc.;
Lahive & Cockfield, LLP, 28 State Street,
Boston, MA 02109 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC
LK LR LS LT LU LV MA MD MG MK MN
MW MX MZ NO NZ PL PT RO RU SD SE
SG SI SK SL TJ TM TR TT TZ UA UG US
UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 C12N 15/12, 15/62, 15/10, C07K 14/47,
16/18, C12Q 1/68, G01N 33/53
(11) WO 01/83753 (13) A2
(21) PCT/US01/14283
(22) 3 May/mai 2001 (03.05.2001)
(25) en (26) en
(30) 60/201,464 3 May/mai 2000 US
(03.05.2000)
(43) 8 Nov/nov 2001 (08.11.2001)
(54) NOVEL MOLECULES OF THE
NBS/LRR PROTEIN FAMILY AND
USES THEREOF
NOUVELLES MOLECULES APPARTE-
NANT A LA FAMILLE DE PROTEINES
NBS/LRR ET UTILISATIONS DE CES
DERNIERES
(71) MILLENNIUM PHARMACEUTICALS,
INC. [US/US]; 73 Sidney Street, Cambridge,
MA 02139 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) BERTIN, John [US/US]; Apartment 1,
475 Arsenal Street, Watertown, MA 02172
(US).
(74) MIEKLEJOHN, Anita, L. et al. / etc.;
Fish & Richardson, P.C., 225 Franklin Street,
Boston, MA 02110-2804 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC
LK LR LS LT LU LV MA MD MG MK MN
MW MX MZ NO NZ PL PT RO RU SD SE
SG SI SK SL TJ TM TR TT TZ UA UG US
UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 C12N 15/12, 15/11, 9/00, C07K 14/47,
C12Q 1/68, A61K 31/7088 // A61P 31/14
(11) WO 01/83754 (13) A2
(21) PCT/US01/14337
(22) 2 May/mai 2001 (02.05.2001)
(25) en (26) en
(30) 09/563,794 2 May/mai 2000 US
(02.05.2000)
(43) 8 Nov/nov 2001 (08.11.2001)
(54) CELLULAR REGULATORS OF INFEC-
TIOUS AGENTS AND METHODS OF
USE
REGULATEURS CELLULAIRES
D’AGENTS INFECTIEUX ET ME-
THODES D’UTILISATIONS
(63) US 09/563,794 (CON)
2 May/mai 2000 (02.05.2000)
(71) IMMUSOL, INCORPORATED [US/US];
10790 Roselle Street, San Diego, CA 92121
(US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) KRUGER, Martin [DE/DE]; Kronsberger
Strasse 20, 30559 Hannover (DE).
WELCH, Peter, J. [US/US]; 4689 East Talmadge
Drive, San Diego, CA 92116 (US).
BARBER, Jack, R. [US/US]; 11987 Caneridge
Place, San Diego, CA 92128 (US).
(74) WILSON, Barry, S. et al. / etc.; Foley &
Lardner, Suite 23, 402 West Broadway, San
Diego, CA 92101-3542 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC
LK LR LS LT LU LV MA MD MG MK MN
MW MX MZ NO NZ PL PT RO RU SD SE
SG SI SK SL TJ TM TR TT TZ UA UG US
UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 C12N 15/13, C07K 16/28, C12N 5/20,
5/10, A61K 39/395, A61P 35/00, 37/06,
31/00, G01N 33/68, 33/577
(11) WO 01/83755 (13) A2
(21) PCT/US01/13672
(22) 27 Apr/avr 2001 (27.04.2001)
(25) en (26) en
(30) 60/200,601 28 Apr/avr 2000 US
(28.04.2000)
(43) 8 Nov/nov 2001 (08.11.2001)
(54) HUMAN ANTI-CD40 ANTIBODIES
AND METHODS OF MAKING AND
USING SAME
ANTICORPS HUMAINS ANTI-CD40,
ET LEURS PROCEDES DE PRODUC-
TION ET D’UTILISATION
(71) GEMINI SCIENCE, INC. [US/US]; Suite
940, 4275 Executive Square, La Jolla, CA
92037 (US).